Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Fulgent Genetics Q1 Adj. EPS $0.04 Beats $(0.18) Estimate, Sales $73.46M Beat $71.26M Estimate

Author: Benzinga Newsdesk | May 02, 2025 06:01am
Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.18) by 122.22 percent. This is a 500 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $73.46 million which beat the analyst consensus estimate of $71.26 million by 3.10 percent. This is a 13.92 percent increase over sales of $64.48 million the same period last year.

Posted In: FLGT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist